The U.S. Food and Drug Administration has approved Axsome Therapeutics' migraine treatment, the company said on Thursday.
All things considered, it’s at least as likely to make health outcomes worse as it is to make most people healthier.
Readers had a lot to say about my latest column on the Food and Drug Administration’s proposed front-of-package labels. Most ...
The oversight could result in “death,” at least for those with a milk allergy or sensitivity, says the FDA. FDA initiated the ...
(Reuters) - The U.S. Food and Drug Administration (FDA) said on Thursday it had identified three cybersecurity risks ...
The U.S. Food and Drug Administration’s recent approval of a product known as Zyn is a leap forward for the cause of tobacco ...
STATEN ISLAND, N.Y. — A December 2024 chocolate recall has been upgraded to highest risk level by the U.S. Food and Drug ...
The FDA has upgraded a recall of Lay’s Potato Chips to the highest level possible, meaning consuming the chips will cause ...
The FDA just set the highest risk level—class 1—for the recall of Lay's Classic Potato Chips amid concern that they contain ...
The FDA’s approval of Ozempic to battle chronic kidney disease “allows us to more broadly address conditions within cardiovascular-kidney-metabolic syndrome, which affects millions of ...
STATEN ISLAND, N.Y. — A December 2024 chocolate recall has been upgraded to highest risk level by the U.S. Food and Drug ...